A citation-based method for searching scientific literature

Johan O Paulsson, Ninni Mu, Ivan Shabo, Na Wang, Jan Zedenius, Catharina Larsson, C Christofer Juhlin. Endocr Relat Cancer 2018
Times Cited: 24







List of co-cited articles
120 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Na Wang, Tiantian Liu, Anastasios Sofiadis, C Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, Dawei Xu. Cancer 2014
73
54

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
300
45

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
360
41

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
41

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
41

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
158
41

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
255
37

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
177
37


TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.
Martin Hysek, Johan O Paulsson, Na Wang, Kenbugul Jatta, Claes Lindh, Nelson Fuentes-Martinez, Ivan Shabo, Jan Zedenius, C Christofer Juhlin. Virchows Arch 2018
12
58

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
515
29


Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
458
29

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
380
29

Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization.
Marina Muzza, Carla Colombo, Stefania Rossi, Delfina Tosi, Valentina Cirello, Michela Perrino, Simone De Leo, Elisa Magnani, Elisa Pignatti, Beatrice Vigo,[...]. Mol Cell Endocrinol 2015
77
25

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.
Martin Hysek, Johan O Paulsson, Kenbugul Jatta, Ivan Shabo, Adam Stenman, Anders Höög, Catharina Larsson, Jan Zedenius, Carl Christofer Juhlin. Cancers (Basel) 2019
18
33

TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma.
Claire Bournaud, Françoise Descotes, Myriam Decaussin-Petrucci, Julien Berthiller, Christelle de la Fouchardière, Anne-Laure Giraudet, Mireille Bertholon-Gregoire, Philip Robinson, Jean-Christophe Lifante, Jonathan Lopez,[...]. Eur J Cancer 2019
22
22

Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.
Naoki Oishi, Tetsuo Kondo, Aya Ebina, Yukiko Sato, Junko Akaishi, Rumi Hino, Noriko Yamamoto, Kunio Mochizuki, Tadao Nakazawa, Hiroshi Yokomichi,[...]. Mod Pathol 2017
37
20

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma.
Johan O Paulsson, Anton Olander, Felix Haglund, Jan Zedenius, C Christofer Juhlin. Endocr Pathol 2018
8
62

Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer.
Federica Panebianco, Alyaksandr V Nikitski, Marina N Nikiforova, Yuri E Nikiforov. Cancer Med 2019
16
31

Mutation profiles of follicular thyroid tumors by targeted sequencing.
Huanli Duan, Xiaoding Liu, Xinyu Ren, Hui Zhang, Huanwen Wu, Zhiyong Liang. Diagn Pathol 2019
16
31

Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology.
Norman G Nicolson, Timothy D Murtha, Weilai Dong, Johan O Paulsson, Jungmin Choi, Andrea L Barbieri, Taylor C Brown, John W Kunstman, Catharina Larsson, Manju L Prasad,[...]. J Clin Endocrinol Metab 2018
31
20

A PCR-based expression signature of malignancy in follicular thyroid tumors.
Theodoros Foukakis, Arief Gusnanto, Amy Y M Au, Anders Höög, Weng-Onn Lui, Catharina Larsson, Göran Wallin, Jan Zedenius. Endocr Relat Cancer 2007
42
16

TERT, HRAS, and EIF1AX Mutations in a Patient with Follicular Adenoma.
Michael C Topf, Zi-Xuan Wang, Madalina Tuluc, Edmund A Pribitkin. Thyroid 2018
13
30

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
Xiaoli Liu, Shen Qu, Rengyun Liu, Chunjun Sheng, Xiaoguang Shi, Guangwu Zhu, Avaniyapuram Kannan Murugan, Haixia Guan, Hongyu Yu, Yangang Wang,[...]. J Clin Endocrinol Metab 2014
180
16


Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
289
16


Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.
Seong-Keun Yoo, Seungbok Lee, Su-Jin Kim, Hyeon-Gun Jee, Byoung-Ae Kim, Hyesun Cho, Young Shin Song, Sun Wook Cho, Jae-Kyung Won, Jong-Yeon Shin,[...]. PLoS Genet 2016
139
16

Low frequency of TERT promoter mutations in a series of well-differentiated follicular-patterned thyroid neoplasms.
A Proietti, C Sartori, E Macerola, N Borrelli, G Materazzi, P Vitti, F Basolo. Virchows Arch 2017
9
33

Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.
Na Wang, Hanna Kjellin, Anastasios Sofiadis, Omid Fotouhi, C Christofer Juhlin, Martin Bäckdahl, Jan Zedenius, Dawei Xu, Janne Lehtiö, Catharina Larsson. Oncotarget 2016
29
12

Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene.
S Renaud, D Loukinov, Z Abdullaev, I Guilleret, F T Bosman, V Lobanenkov, J Benhattar. Nucleic Acids Res 2007
134
12


Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas.
Tareq A Juratli, Christian Thiede, Mara V A Koerner, Shilpa S Tummala, Dirk Daubner, Ganesh M Shankar, Erik A Williams, Maria Martinez-Lage, Silke Soucek, Katja Robel,[...]. Oncotarget 2017
51
12

Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC.
Jonathan R George, Ying C Henderson, Michelle D Williams, Dianna B Roberts, Hu Hei, Stephen Y Lai, Gary L Clayman. J Clin Endocrinol Metab 2015
44
12

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, Denis Gallagher, Cindy Zhang, Tatiana Lipman, Nataliya Zhukova, Erin J Walker, Dianna Martin, Diana Merino,[...]. Lancet Oncol 2013
148
12

Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
Rong Bu, Abdul K Siraj, Sasidharan Padmaja Divya, Yan Kong, Sandeep Kumar Parvathareddy, Maha Al-Rasheed, Khadija A S Al-Obaisi, Ingrid G Victoria, Saif S Al-Sobhi, Mohammed Al-Dawish,[...]. Int J Cancer 2018
31
12

TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
Ebtesam Qasem, Avaniyapuram Kannan Murugan, Hindi Al-Hindi, Mingzhao Xing, Mai Almohanna, Meshael Alswailem, Ali S Alzahrani. Endocr Relat Cancer 2015
31
12

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
12

Frequent amplification of the telomerase reverse transcriptase gene in human tumors.
A Zhang, C Zheng, C Lindvall, M Hou, J Ekedahl, R Lewensohn, Z Yan, X Yang, M Henriksson, E Blennow,[...]. Cancer Res 2000
115
12

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
12

A survey of telomerase activity in human cancer.
J W Shay, S Bacchetti. Eur J Cancer 1997
12

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
Young Shin Song, Jung Ah Lim, Hoonsung Choi, Jae-Kyung Won, Jae Hoon Moon, Sun Wook Cho, Kyu Eun Lee, Young Joo Park, Ka Hee Yi, Do Joon Park,[...]. Cancer 2016
88
12


TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation.
Paula Boaventura, Rui Batista, Ana Pestana, Marta Reis, Adélia Mendes, Catarina Eloy, Manuel Sobrinho-Simões, Paula Soares. Eur J Endocrinol 2017
8
37

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
12

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
Marina N Nikiforova, Roy A Lynch, Paul W Biddinger, Erik K Alexander, Gerald W Dorn, Giovanni Tallini, Todd G Kroll, Yuri E Nikiforov. J Clin Endocrinol Metab 2003
469
12

GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Xiaotian Yuan, Ninni Mu, Na Wang, Klas Strååt, Anastasios Sofiadis, Yanxia Guo, Adam Stenman, Kailin Li, Guanghui Cheng, Lu Zhang,[...]. Oncogene 2019
21
14

The Incidence and Survival of Rare Cancers of the Thyroid, Parathyroid, Adrenal, and Pancreas.
Benjamin C James, Briseis Aschebrook-Kilfoy, Nicole Cipriani, Edwin L Kaplan, Peter Angelos, Raymon H Grogan. Ann Surg Oncol 2016
19
15

TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.
Aya Tanaka, Michiko Matsuse, Vladimir Saenko, Tomoe Nakao, Kosho Yamanouchi, Chika Sakimura, Hiroshi Yano, Eijun Nishihara, Mitsuyoshi Hirokawa, Keiji Suzuki,[...]. Thyroid 2019
16
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.